ADGRL3 and attention deficit-hyperactivity disorder: Recently, LPHN3 has been linked to attention deficit hyperactivity disorder (ADHD); polymorphisms in LPHN3 are risk factors for ADHD [2,3] and LPHN3 haplotype can predict the efficacy of stimulant treatment [4] and human cortical electrophysiology [5].